GOLDMAN SACHS GROUP INC - TEKMIRA PHARMACEUTICALS CORP ownership

TEKMIRA PHARMACEUTICALS CORP's ticker is TKMR and the CUSIP is 87911B209. A total of 79 filers reported holding TEKMIRA PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TEKMIRA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$9,175,000
+7.1%
773,578
+57.6%
0.00%0.0%
Q1 2015$8,569,000
+827.4%
490,782
+1022.8%
0.00%
Q3 2014$924,000
+303.5%
43,712
+148.8%
0.00%
Q2 2014$229,000
-55.0%
17,567
-25.9%
0.00%
Q1 2014$509,000
+338.8%
23,710
+62.9%
0.00%
Q4 2013$116,00014,5570.00%
Other shareholders
TEKMIRA PHARMACEUTICALS CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Orinda Asset Management LLC 30,209$241,0000.54%
SABBY MANAGEMENT, LLC 519,200$4,138,0000.26%
MARXE AUSTIN W & GREENHOUSE DAVID M 245,562$1,957,0000.21%
BAILARD, INC. 115,795$923,0000.15%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 95,897$764,0000.06%
Baker Brothers Advisors 500,000$3,985,0000.06%
PointState Capital LP 348,000$2,774,0000.04%
SHEPHERD KAPLAN KROCHUK, LLC 17,418$139,0000.02%
Highlander Capital Management, LLC 2,000$15,940,0000.02%
Spark Investment Management LLC 10,300$81,0000.01%
View complete list of TEKMIRA PHARMACEUTICALS CORP shareholders